switching from compounded tirzepatide to zepbound versions of (Mounjaro, Zepbound) containing vitamin B12 pose a potential safety risk the public, Eli Lilly warned in an open letter on Thursday. Following laboratory testing, the drugmaker said TrimRX | Can You Switch
Description
(2022) 11:e026728

We offer a rich selection of peptides tailored to various health needs
Dispose of it properly and prepare a new solution if necessary
.jpg)
Whilst not an officially recognised adverse effect in regulatory documentation from the MHRA or EMA, anecdotal reports have prompted questions about potential links

Reliable information about the availability of the drugs is hard to come by
